Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jianfen Zhu"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF) or immune checkpoint inhibitors (ICIs) combined with chemotherapy are commonly administered to cancer patients. Although cancer patients receiving anti-VEGF o
Externí odkaz:
https://doaj.org/article/f67a5165469341be9490bae645ffbbd8
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Objective Polycystic ovary syndrome (PCOS) is an endocrine gynecological disease affecting many women of reproductive age. Clomiphene is the first-line treatment for PCOS patients, but most individuals may be resistant to it. This study aims
Externí odkaz:
https://doaj.org/article/00324e4c51cf4e48ac67a8e5321c5e1b
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Background and objectives Acute kidney injury (AKI) is one of the most common and severe clinical syndromes of diffuse proliferative lupus nephritis (DPLN), of which poor prognosis is indicated by aggravated renal function deterioration. However, the
Externí odkaz:
https://doaj.org/article/e6cc498c40ba445ea5e901abc36d3e02
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-7 (2022)
Abstract Background and objectives The clinical and pathological impact factors for renal function recovery in acute kidney injury (AKI) on the progression of renal function in primary membranous nephropathy (PMN) with AKI patients have not yet been
Externí odkaz:
https://doaj.org/article/222790e2a945464bae55ccc2ce5acd2d
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Sepsis-induced AKI (SIAKI) is the most common complication with unacceptable mortality in hospitalized and critically ill patients. The pathophysiology of the development of SIAKI is still poorly understood. Our recent work has demonstrated the role
Externí odkaz:
https://doaj.org/article/4ffe6a0d81cd4b64a019b7334b596ff9
Publikováno v:
Journal of Raman Spectroscopy. 54:532-539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7240d7f97759085879b8900a43d9bd39
https://doi.org/10.1002/jrs.6515
https://doi.org/10.1002/jrs.6515
Autor:
Yanqun Wang, Zhaoyong Zhang, Minnan Yang, Xinyi Xiong, Qihong Yan, Lei Cao, Peilan Wei, Yuting Zhang, Lu Zhang, Kexin Lv, Jiantao Chen, Xuesong Liu, Xiaochu Zhao, Juxue Xiao, Shengnan Zhang, Airu Zhu, Mian Gan, Jingjun Zhang, Ruoxi Cai, Jianfen Zhuo, Yanjun Zhang, Haiyue Rao, Bin Qu, Yuanyuan Zhang, Lei Chen, Jun Dai, Linling Cheng, Qingtao Hu, Yaoqing Chen, Huibin Lv, Ray T.Y. So, Malik Peiris, Jingxian Zhao, Xiaoqing Liu, Chris Ka Pun Mok, Xiangxi Wang, Jincun Zhao
Publikováno v:
Cell Reports, Vol 43, Iss 1, Pp 113653- (2024)
Summary: Omicron, as the emerging variant with enhanced vaccine tolerance, has sharply disrupted most therapeutic antibodies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the subgenus Sarbecovirus, members of which share hi
Externí odkaz:
https://doaj.org/article/08a7908f7f674401bcbdd5e3709922fc
Autor:
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, Zhao Chen, Shengnan Zhang, Airu Zhu, Jingxian Zhao, Jincun Zhao
Publikováno v:
Vaccines, Vol 12, Iss 5, p 478 (2024)
Despite significant strides in vaccine research and the availability of vaccines for many infectious diseases, the threat posed by both known and emerging infectious diseases persists. Moreover, breakthrough infections following vaccination remain a
Externí odkaz:
https://doaj.org/article/974819dc18a74beaadaff6a1b78cfced
Autor:
Yuming Li, Guixue Hou, Haibo Zhou, Yanqun Wang, Hein Min Tun, Airu Zhu, Jingxian Zhao, Fei Xiao, Shanwen Lin, Dongdong Liu, Dunrong Zhou, Lang Mai, Lu Zhang, Zhaoyong Zhang, Lijun Kuang, Jiao Guan, Qiushi Chen, Liyan Wen, Yanjun Zhang, Jianfen Zhuo, Fang Li, Zhen Zhuang, Zhao Chen, Ling Luo, Donglan Liu, Chunke Chen, Mian Gan, Nanshan Zhong, Jincun Zhao, Yan Ren, Yonghao Xu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract Disease progression prediction and therapeutic drug target discovery for Coronavirus disease 2019 (COVID-19) are particularly important, as there is still no effective strategy for severe COVID-19 patient treatment. Herein, we performed mult
Externí odkaz:
https://doaj.org/article/0bb9c81df58b4db7ae229257d20afc55
Autor:
Baolin Liao, Zhao Chen, Peiyan Zheng, Linghua Li, Jianfen Zhuo, Fang Li, Suxiang Li, Dingbin Chen, Chunyan Wen, Weiping Cai, Shanhui Wu, Yanhong Tang, Linwei Duan, Peilan Wei, Fangli Chen, Jinwei Yuan, Jinghong Yang, Jiaxin Feng, Jingxian Zhao, Jincun Zhao, Baoqing Sun, Airu Zhu, Yimin Li, Xiaoping Tang
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Characterizing the serologic features of asymptomatic SARS-CoV-2 infection is imperative to improve diagnostics and control of SARS-CoV-2 transmission. In this study, we evaluated the antibody profiles in 272 plasma samples collected from 59 COVID-19
Externí odkaz:
https://doaj.org/article/5f32db5b22d24e55b5ab9b141c50d57a